Indiana Code

Ind. Code § 35-48-2-8 (2026)

Schedule III

✓ current as of May 2026

Find cases: SyfertCases citing this section JustiaInd. Code CornellLII Search CasesGoogle Scholar

Sec. 8. (a) The controlled substances listed in this section are included in schedule III.

(b) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on April 1, 1986, as excepted compounds under 21 CFR 1308.32, and any other drug of the quantitative composition shown in that list for those drugs or that is the same except that it contains a lesser quantity of controlled substances (1405).

(2) Benzphetamine (1228).

(3) Chlorphentermine (1645).

(4) Clortermine (1647).

(5) Phendimetrazine (1615).

(c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

(1) Any compound, mixture, or preparation containing:

(A) amobarbital (2126);

(B) secobarbital (2316);

(D) any of their salts;

and one (1) or more other active medicinal ingredients which are not listed in any schedule.

(2) Any suppository dosage form containing:

(A) amobarbital (2126);

(B) secobarbital (2316);

(D) any of their salts;

and approved by the Food and Drug Administration for marketing only as a suppository.

(3) Any substance which contains any quantity of a derivative of barbituric acid, or any salt thereof (2100).

(4) Chlorhexadol (2510).

(5) Embutramide (2020).

(6) Lysergic acid (7300).

(7) Lysergic acid amide (7310).

(8) Methyprylon (2575).

(9) Sulfondiethylmethane (2600).

(10) Sulfonethylmethane (2605).

(11) Sulfonmethane (2610).

(12) A combination product containing Tiletamine and Zolazepam or any salt thereof (Telazol) (7295).

(13) Any drug product containing gamma-hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the federal Food, Drug and Cosmetic Act, 21 U.S.C. 301 et seq. (2012).

(d) Nalorphine (a narcotic drug) (9400).

(e) Narcotic Drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in the following limited quantities:

(1) Not more than 1.8 grams of codeine, per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium (9803).

(2) Not more than 1.8 grams of codeine, per 100 milliliters or not more than 90 milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts (9804).

(3) Not more than 1.8 grams of dihydrocodeine, per 100 milliliters or not more than 90 milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts (9807).

(4) Not more than 300 milligrams of ethylmorphine, per 100 milliliters or not more than 15 milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts (9808).

(5) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts (9809).

(6) Not more than 50 milligrams of morphine, per 100 milliliters or per 100 grams with one (1) or more active nonnarcotic ingredients in recognized therapeutic amounts (9810).

(7) Buprenorphine (9064).

(f) Anabolic steroid (as defined in 21 U.S.C. 802(41)(A) and 21 U.S.C. 802(41)(B)).

(g) The board shall except by rule any compound, mixture, or preparation containing any stimulant or depressant substance listed in subsections (b) through (e) from the application of any part of this article if the compound, mixture, or preparation contains one (1) or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.

(h) Any material, compound, mixture, or preparation which contains any quantity of Ketamine (7285).

(i) Hallucinogenic substances:

Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product (7369).

As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1977, P.L.2, SEC.86; Acts 1979, P.L.303, SEC.5; Acts 1981, P.L.170, SEC.4; P.L.333-1983, SEC.3; P.L.200-1987, SEC.10; P.L.48-1991, SEC.76; P.L.1-1994, SEC.171; P.L.31-1998, SEC.10; P.L.288-2001, SEC.16; P.L.22-2008, SEC.3; P.L.56-2015, SEC.4.

Notes of Decisions

Cited in 9 cases, 2007–2020 · leading case: Williams v. State, 930 N.E.2d 602 (Ind. Ct. App. 2010).

Sort: Relevance Newest Treatment

Williams v. State, 930 N.E.2d 602 (Ind. Ct. App. 2010). · cites it 7× “See I.C. § 35-48-2-8. There is no dispute on appeal that, since the State charged Williams twice under the same statute, the statutory elements of those two offenses are identical.”

Mills v. State, 868 N.E.2d 446 (Ind. 2007). · cites it 2× “’’ I.C. § 35-48-2-8(b)(3)(C)(ii) (Supp. 2006).”

Marchand v. Review Bd. of the Indiana Dep't of Workforce Dev., 905 N.E.2d 435 (Ind. Ct. App. 2009). · cites it 2× “See Ind.Code § 35-48-2-8. 2 . The Review Board received Marchand's faxed appeal along with a cover sheet indicating that it had been faxed from her counsel's office.”

Jarod G. Allred v. State of Indiana (Ind. Ct. App. 2014). · cites it 14× “Ind. Code § 35-48-2-8 (e)(2). The chemist testified that the substance was codeine, “a controlled substance,” and acetaminophen.”

Bruce Ashby v. State of Indiana (mem. dec.) (Ind. Ct. App. 2015). · cites it 12× “” Ind. Code § 35-48-2-8 (e)(4) (2008). [13] Ashby argues the evidence was insufficient to support his conviction because the State failed to prove an essential element of the offense.”

Frank M. Hancock v. State of Indiana (mem. dec.) (Ind. Ct. App. 2016). · cites it 2× “Ind. Code Ann. § 35-48-2-8 (e)(4) (West 2012).”

Durrand Anthony Jones v. State of Indiana (mem. dec.) (Ind. Ct. App. 2019). · cites it 2× “§ 35-48-2-6; I.C. § 35-48-2-8; I.C. § 35-48-2-10; I.C.”

ALSTON v. United States (S.D. Ind. 2020). · cites it 2× “Code § 35-48-2-10 (marijuana) and Ind. Code § 35-48-2-8 (b) (methamphetamine) – were broader than the types of drugs found in the federal definition of a felony drug offense.”

Darren Rayford v. State of Indiana (Ind. Ct. App. 2014). · cites it 2× “See I.C. § 35-48-2-8(e)(9). 2 On January 31, 2013, Rayford was placed on probation.”

— Ind. Code § 35-48-2-8(b)(3)(C)(ii) — 1 case

Mills v. State, 868 N.E.2d 446 (Ind. 2007). “’’ I.C. § 35-48-2-8(b)(3)(C)(ii) (Supp. 2006).”

— Ind. Code § 35-48-2-8(e)(2) — 1 case

Bruce Ashby v. State of Indiana (mem. dec.) (Ind. Ct. App. 2015). “” Ind. Code § 35-48-2-8 (e)(4) (2008). [13] Ashby argues the evidence was insufficient to support his conviction because the State failed to prove an essential element of the offense.”

— Ind. Code § 35-48-2-8(e)(4) — 2 cases

Williams v. State, 930 N.E.2d 602 (Ind. Ct. App. 2010). “See I.C. § 35-48-2-8. There is no dispute on appeal that, since the State charged Williams twice under the same statute, the statutory elements of those two offenses are identical.”

Jarod G. Allred v. State of Indiana (Ind. Ct. App. 2014). “Ind. Code § 35-48-2-8 (e)(2). The chemist testified that the substance was codeine, “a controlled substance,” and acetaminophen.”

— Ind. Code § 35-48-2-8(e)(9) — 1 case

Darren Rayford v. State of Indiana (Ind. Ct. App. 2014). “See I.C. § 35-48-2-8(e)(9). 2 On January 31, 2013, Rayford was placed on probation.”

Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.